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	 Novel	 miniaturized	 polyvinyl	 chloride	 membrane	 sensors	 in	 all‐solid	 state	 graphite	 and
platinum	wire	supports	were	developed,	electrochemically	evaluated	and	used	for	the	assay	of
naftidrofuryl	oxalate.	The	naftidrofuryl	oxalate	sensors	were	based	on	the	formation	of	an	ion‐
association	 complex	 between	 the	 drug	 cation	 and	 tetrakis‐(4‐chlorophenyl)borateanionic
exchanger	 as	 electroactive	 material	 and	 sulfocalix‐8‐arene	 as	 ionophore	 dispersed	 in	 a
polyvinyl	chloride	matrix.	Linear	responses	of	10‐2‐10‐6	M	and	10‐2‐10‐5	M	with	cationic	slopes
of	 56.9	 mV	 and	 54.1	 mV	 over	 the	 pH	 range	 2‐5	 were	 obtained	 by	 using	 the	 naftidrofuryl
oxalate‐coated	 graphite	 (Sensor	 1)	 and	 platinum	 wire	 (Sensor	 2)	 membrane	 sensors,
respectively.	 The	 utility	 of	 4‐sulfocalix‐8‐arene	 as	 ionophore	 had	 a	 significant	 influence	 on
increasing	 the	 membrane	 sensitivity	 and	 selectivity.	 The	 methods	 were	 also	 used	 to
determine	the	intact	drug	in	the	presence	of	it’s	degradate	in	Praxilene®	tablets,	plasma	and
cerebrospinal	 fluid	 with	 good	 recovery.	 Sensor	 1	 was	 used	 to	 study	 the	 kinetics	 of
naftidrofuryl	 oxalate	 alkaline	 degradation	 that	 was	 found	 to	 follow	 a	 pseudo	 first‐order
reaction.	 The	 activation	 energy	 could	 be	 estimated	 from	 the	 Arrhenius	 plot	 to	 be	 12.572
Kcal/mol.	
Potentiometry	
Cerebrospinal	fluid	
4‐Sulfocalix‐8‐arene	
Naftidrofuryl	oxalate	
Stabilityindicating	method	
Tetrakis‐(4‐chlorophenyl)borate	
	
1.	Introduction	
	
Naftidrofuryl,	 (RS)‐2‐(diethylamino)ethyl‐3‐(1‐naphthyl)‐
2‐(tetrahydrofuran‐2‐ylmethyl)propanoate	 (C24H33NO3	
([31329‐57‐4]	 [1])	 known	 as	nafronyl	is	 a	 drug	 used	 in	 the	
management	 of	 peripheral	 and	cerebral	vascular	 disorders	
(Figure	1).	 It	 is	 claimed	 to	enhance	cellular	oxidative	capacity	
and	 has	 a	spasmolytic	 activity.	 It	 may	 also	 be	 a	5‐hydroxy	
tryptamine	 (5‐HT2)	 receptor	antagonist.	 It	 is	 also	 licensed	 for	
the	 treatment	 of	intermittent	 claudication	due	 to	 peripheral	
arterial	disease	[2].	
	
	
Figure	1.	The	structure	of	naftidrofuryl	oxalate.
	
Several	methods	have	been	reported	for	the	determination	
of	 naftidrofuryl	 (NFT),	 these	 include	 titrimetric	 method	 [3],	
spectrophotometric	 [4‐7]	 high	 performance	 liquid	 chromate‐
graphic	 [8‐14],	 thin	 layer	 chromatographic	 [7]	 capillary	 zone	
electrophoresis	 [15‐17],	 phosphorimetric	 [18‐23],	 electro‐
chemical	[5,24,25]	and	chemometric	[13]	methods.	
From	 these	 procedures,	 only	 the	 spectroscopic	 [7]	 HPLC	
techniques	 [9,13,14],	 TLC	 [7]	 and	 electrochemical	 [25]	 were	
recommended	 as	 stability	 indicating	 assays.	 Ion	 selective	
electrodes	 have	 been	 reported	 for	 the	 determination	 of	 NFT	
using	a	precipitation‐based	 technique	with	dipicrylamine	 [24]	
tetra	phenyl	borate	&	ammonium	reineckate	[25]	as	an	anionic	
exchanger	 without	 incorporation	 of	 ionophores&	 using	 a	 β‐
cyclodextrin	 as	 ionophore	 without	 incorporation	 of	 ion	
association	 complex.	 Also	 their	 selectivity	 coefficients	 were	
only	tested	for	a	few	organic	and	inorganic	cations.	
Calixarenes	are	cavity‐shaped	cyclic	oligomers	made	up	of	
phenol	units	 linked	via	 alkylidene	groups.	 Their	 configuration	
includes	 a	 number	 of	 selective	 factors,	 such	 as	 cavity‐size,	
conformation	and	substituents,	which	leads	to	the	formation	of	
typical	 host‐guest	 complexes	 with	 numerous	 compounds	 and	
allow	 for	a	variety	of	applications	 in	 ion‐selective	membranes	
and	electrodes	[26‐28].	
Calixarenes	are	well‐known	as	selective	ligands	for	various	
ions	 through	dipole‐dipole	 interactions,	 as	 shown	 in	Figure	2.	
They	 can	 complex	with	 a	 large	 variety	 of	 cation	 substrates	 to	
form	 stable	 host‐guest	 inclusion	 complexes.	 This	 property	 of	
calixarenes	has	been	largely	exploited	for	the	development	of	a	
number	of	cation	selective	electrodes	[29‐32].	
Microelectrodes	 are	 the	 subject	 of	 many	 researches	 in	
recent	 years	 and	 the	 advantages	 they	 offer	 over	 conventional	
electrodes	are	well	known	[33‐35].	Metallic	and	graphite‐based	
conductors	 of	 many	 geometric	 shapes	 have	 been	 suggested,	
such	 as	 wire,	 disc	 and	 cylinders	 [36,37].	 These	 electrodes	
behave	 as	 two	 interface	 devices,	 membrane/electrolyte	
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interface	 and	 membrane/metal	 interface	 [38].	 Coated	 wire	
electrodes	(CWEs)	for	some	cations	and	anions	were	described	
[39‐41].	Also	coated	graphite	rods	were	used	as	sensors	for	the	
determination	of	 some	drugs	 such	 as	 atenolol	 [42],	 tizanidine	
[43]	and	rivastigmine	[44].	
	
	(A)	
	
	(B)	
	
Figure	2.	(A)	Chemical	structure	of	the	4‐sulfocalix‐8‐arene	molecule.	(B)	
Mode	of	attachment	between	the	sulphonic	acid	groups	of	4‐sulfocalix‐8‐
arene	and	NFT. 
	
The	 present	 work	 described	 the	 use	 of	 tetrakis‐(4‐chloro	
phenyl)borate	 (TpClPB)as	 anionic	 exchanger	 and	 sulphonated	
calyx‐8‐arene	 as	 neutral	 ionophore	 for	 the	 development	 of	
novel	 sensors	 for	 the	 determination	 of	 NFT.	 These	 sensors	
were	 used	 for	 the	 determination	 of	 NFT	 in	 bulk	 powder,	
different	 pharmaceutical	 formulations,	 and	 biological	 fluid	
(plasma	 and	 CSF)	 and	 in	 the	 presence	 of	 its	 degradation	
product.	A	kinetic	study	is	also	performed.	
The	 novelty	 is	 that	 it	 is	 the	 first	 kinetic	 study	 for	 NFT	
degradation	to	calculate	the	strength	of	this	ester	molecule.	 In	
addition	 that,	 this	 kinetic	 study	 is	monitored	 by	 ion	 selective	
electrodes	 technique,	 which	 is	 more	 simple	 (require	 no	
preliminary	 extraction),	 sensitive	 (wider	 range)	 and	 rapid	
compared	to	the	ordinary	UV	spectroscopy	and	HPLC	methods	
[45].	
	
2.	Experimental	
	
2.1.	Apparatus	
	
All	potentiometric	measurements	were	carried	out	at	25±1	
oC	 with	 a	 Hanna	 (Model	 211)	 pH/mV	 meter	 with	 a	 single‐
junction	 calomel	 reference	 electrode	 (Model	 HI5412)	 used	 in	
conjunction	with	 the	drug	sensor.	A	Hanna	pH	glass	electrode	
part	 code	 HI	 1131B,	 Lot	 no.	 30565	 (Romania)	 and	 a	
Bandelinsonorox	magnetic	 stirrer	model	 Rx	 510	 S	 (Budapest,	
Hungary)	were	 used	 for	 pH	 adjustments.	 The	 used	 precoated	
HPTLC	plates,	silica	gel	60F245	20x20	cm,	0.2	nm	thickness,	was	
obtained	from	Macheray‐Nagel	(Germany).	
	
2.2.	Chemicals	and	reagents	
	
Naftidrofuryl	oxalate	(Mol.	wt.	473.6	g)	was	kindly	supplied	
by	MINAPHARM,	Egypt	under	license	of	MERCK	France,	having	
a	 purity	 of	 100.28±1.12.	 Its	 purity	 was	 also	 checked	 in	 our	
laboratory	 according	 to	 non	 aqueous	 titrimetric	 method	 [3].	
Praxilene®	 film	 coated	 tablets	 (MINAPHARM,	 Egypt	 under	
license	of	MERCK	Serono	France)	 labeled	to	contain	200mg	of	
NFT	 per	 tablet,	 batch	 number	 cee1446,cce	 0886were	
purchased	from	the	Egyptian	market.	
All	chemicals	and	reagents	used	were	of	analytical	reagent	
grade,	and	water	was	bi‐distilled	deionized.	Polyvinyl	chloride	
(PVC	 high	 molecular	 weight),	 4‐sulfocalix‐8‐arene	 were	
obtained	from	Fluka	(Steinheim,	Germany).	2‐Nitrophenyl	octyl	
ether	 (NPOE)	was	purchased	 from	Sigma	 (St.Louis,	MO,	USA).	
Tetrakis‐(4‐chlorophenyl)borate	(TpClPB),	2‐(dimethyl	amino)	
ethanol	 solution	 were	 purchased	 from	 Aldrich	 (Steinheim,	
Germany).	 Tetrahydrofuran	 (THF)	 99%	 was	 from	 Lab	 Scan,	
ammonium	 sulphate,	 sodium	 hydroxide	 and	 methanol	 were	
obtained	from	Prolabo	(Pennsylvania,	USA).	
Britton‐Robinson	buffer	(BRB)	(pH=	2‐12)	was	prepared	by	
mixing	different	volumes	of	0.04	mol/L	acetic	acid,	0.04	mol/L	
phosphoric	 acid,	0.04	mol/L	boric	 acid	 and	0.2	mol/L	 sodium	
hydroxide.	 Plasma	 and	 cerebrospinal	 fluid	 were	 supplied	 by	
VACSERA	(Giza,	Egypt)	and	used	within	24	h.	
	
2.3.	Procedures	
	
2.3.1.	Preparation	of	the	degradation	product	of	
naftidrofuryl	oxalate	
	
Two	hundred	and	fifty	milligrams	of	NFT	were	dissolved	in	
10	mL	methanol.	Ten	mL	of	1	M	sodium	hydroxide	was	added	
and	completed	to	50	mL	with	water,	then	refluxed	at	100	oC	for	
4	hours.	One	mL	was	 taken,	 cooled	 to	 room	 temperature	 and	
then	diluted	with	2	mL	methanol	to	be	spotted	on	HPTLC	plates	
against	 the	 standard	 solution.	 The	 plates	 were	 placed	 in	
chromatographic	 tanks	 previously	 saturated	 for	 1	 h	 with	 the	
mobile	phase	of	 chloroform:	methanol	 (8:2,	v:v)	 and	 then	 air‐
dried.	The	spots	were	visualized	under	UV	light	at	254	nm.	The	
solution	was	neutralized	by	1	M	hydrochloric	acid,	evaporated	
to	 dryness	 on	 boiling	 water	 bath	 and	 then	 the	 residue	 was	
dissolved	 in	20	mL	methanol,	 filtered	and	 left	 to	 evaporate	 at	
room	temperature	(25	oC)	to	obtain	the	degradation	product.	
	
2.3.2.	Preparation	of	electroactive	coating	membrane	
	
In	a	Petri	dish	(5‐cm	diameter),	0.01	g	of	TpCIPB	and	0.04	g	
of	4‐sulfocalix‐8‐arene	was	mixed	with	0.35	g	oNPOE	then	0.19	
g	of	PVC	was	added	and	repeat	mixing	then	dissolved	in	5	mL	
tetrahydrofuran.	The	petri	dish	was	covered	with	a	filter	paper	
and	left	to	stand	for	one	hour	to	allow	slow	evaporation	of	the	
solvent,	 producing	 a	 thick	 homogeneous	 master	 coating	 PVC	
solution	[46].	
	
2.3.3.	Sensors	fabrication	[44,47]	
	
2.3.3.1.	Sensor	1	fabrication	(NFT‐coated	graphite	electrode)	
	
A	rod	of	spectrographic	graphite	(6	mm	in	diameter	and	15	
mm	 long)	was	 inserted	 in	 a	 polyethylene	 sleeve,	 and	 about	 3	
mm	 of	 the	 other	 end	 of	 the	 protruded	 rod	 served	 as	 a	
measuring	 surface.	 This	 end	 of	 the	 rod	 was	 washed	 with	
acetone,	 dried	 in	 air	 for	 three	 hours,	 and	 dipped	 rapidly	 into	
the	previously	prepared	PVC	solution.	The	solvent	was	allowed	
to	evaporate	in	air	after	each	dipping,	and	the	dipping	process	
was	repeated	6‐8	times	to	produce	a	uniform	membrane	on	the	
surface	of	the	graphite	rod.	One	drop	of	mercury	was	added	in	
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the	 polyethylene	 sleeve	 to	 ensure	 electrical	 contact	 with	 the	
connection	cable.	The	coated	graphite	rod	was	conditioned	by	
soaking	 in	a	10‐2	M	NFT	solution	 for	 five	hours,	 and	stored	 in	
the	same	solution	when	not	in	use.	
	
2.3.3.2.	Sensor	2	fabrication	(NFT‐coated	platinum	wire	
electrode)	
	
The	cover	of	an	insulated	platinum	wire	(2	mm	in	diameter	
and	10	mm	in	length)	was	removed	for	a	length	of	about	1	cm	
at	 both	 ends.	 One	 end	 of	 the	 wire	 was	 immersed	 in	 the	
previously	prepared	PVC	solution	and	was	 left	to	stand	for	10	
min	 to	 allow	 complete	 air	 drying,	 forming	 a	 thin	 membrane	
around	 the	 wire	 end.	 The	 resultant	 coated	 wire	 membrane	
sensor	was	conditioned	in	10‐2	M	drug	solution	for	three	hours	
and	was	stored	in	the	same	solution	when	not	in	use.	
	
2.3.4.	Sensor	calibration	
	
The	 prepared	 electrodes	 in	 conjunction	 with	 the	 single‐
junction	 calomel	 reference	 electrode	 were	 immersed	 in	
aqueous	 solutions	 of	 (NFT)	 in	 the	 range	 of	 10‐6‐10‐1	 M.	 They	
were	 allowed	 to	 equilibrate	 while	 stirring	 and	 recording	 the	
e.m.f.	 readings	 within	 ±1	 mV.	 The	 membrane	 sensors	 were	
washed	 between	measurements	 with	 water.	 The	 e.m.f	 values	
were	 recorded	 as	 a	 function	 of	 drug	 concentration	 and	 then	
calibration	 graphs	 of	 the	 recorded	 potentials	 versus	 log	 drug	
concentration	were	plotted.	The	above	procedure	was	repeated	
after	 adding	 2	 mL	 of	 2	 mol/L	 (NH4)2SO4	 (ionic	 strength	
adjustor)	to	the	measured	solutions.	
These	 calibration	 graphs	 or	 the	 computed	 regression	
equations	 for	 the	 linear	 part	 of	 the	 curves	 were	 used	 for	
subsequent	 determination	 of	 unknown	 concentrations	 of	
(NFT).	
	
2.3.5.	Effect	of	pH	
	
The	 effect	 of	 pH	 on	 the	 response	 of	 the	 investigated	
electrodes	was	studied	using	10−3	and	10−4	mol/L	solutions	of	
NFT	in	BRB	with	pH	ranging	from	2	to	7.	
	
2.3.6.	Sensors	selectivity	
	
The	 selectivity	 coefficients	 ,( )
pot
A BK 	 of	 the	 proposed	
sensors	 towards	 different	 substances	 were	 determined	 by	 a	
separate	solution	method	using	the	equation	(1)	[48]:	
	
1 2
,log( ) (1 ) log2.303 /
pot A
A B A
A B
E E Z
K
RT Z F Z
    
	 		(1)	
	
where	 ,( )
pot
A BK is	 the	potentiometric	 selectivity	 coefficient,	E1	
is	the	potential	measured	in	10−3	mol/L	NFT	solution,	E2	is	the	
potential	measured	 in	10−3	mol/L	 interferent	 solution,	 ZA	 and	
ZB	are	the	charges	of	NFT	and	interfering	ion,	respectively,	αA	is	
the	activity	of	 the	drug	and	2.303RT/ZAF	represents	 the	slope	
of	the	investigated	sensors	(mV/concentration	decade).	
	
2.3.7.	Application	to	pharmaceutical	formulations	
	
Ten	tablets	were	weighed	and	powdered.	An	amount	of	the	
powder	equivalent	to	0.0236	g	of	(NFT)	was	transferred	to	50	
mL	 volumetric	 flask	 and	 BRB	 buffer,	 pH	 =	 4	 was	 added	 to	
prepare	 a	 10‐3	M	 aqueous	 solution	of	 (NFT).	 The	 e.m.f.	 values	
produced	were	recorded	by	immersing	the	prepared	electrodes	
in	 conjunction	 with	 the	 single‐junction	 calomel	 reference	
electrode	 in	 the	 prepared	 solutions	 then	 the	 concentration	 of	
(NFT)	 was	 determined	 from	 the	 calibration	 curve	 of	 the	
corresponding	electrode.	
2.3.8.	Application	to	plasma	samples	
	
Nine	milliliters	of	plasma	was	placed	in	6	stoppered	20mL	
shaking	tubes,	then	spiked	with	1	mL	of	10‐4	and	10‐5	M	NFT	in	
BRB	buffer,	pH	=	4	separately	and	shaken.	The	solutions	were	
transferred	into	a	dry	25mL	beaker.	The	e.m.f.	values	produced	
by	immersing	the	prepared	electrodes	 in	conjunction	with	the	
single‐junction	 calomel	 reference	 electrode	 in	 the	 spiked	
plasma	 were	 recorded	 then	 the	 concentration	 of	 NFT	 was	
determined	 from	 the	 calibration	 curve	 of	 the	 corresponding	
electrode.	
	
2.3.9.	Determination	of	NFT	in	CSF	
	
One	milliliter	of	10−4	and	of	10−5	mol/L	NFT	solution	in	BRB	
buffer,	 pH	 =	 4	were	 added	 separately	 to	 two	 25	mL	 beakers.	
Each	contained	9	mL	of	CSF	and	the	beakers	were	vortexed	for	
1	min.	The	membrane	 sensors	were	 immersed	 in	 conjunction	
with	 the	 reference	 electrode	 in	 these	 solutions	 and	 then	
washed	 with	 water	 between	 measurements.	 The	 e.m.f.	
produced	 for	 each	 solution	 was	 measured	 by	 the	 proposed	
sensors	 then	 the	 concentration	 of	 NFT	 was	 determined	 from	
the	corresponding	regression	equation.	
	
2.3.10.	Kinetic	studies	
	
2.3.10.1.	For	studying	the	order	of	the	reaction	
	
Into	a	50	mL	measuring	flask,	0.25	g	of	NFT	in	0.2	M	NaOH	
was	 dissolved	 and	 completed	 to	 the	 mark	 with	 the	 same	
solvent.	 This	 solution	was	 transferred	 into	 another	 clean	 dry	
conical	flask	and	refluxed	in	a	thermostatically	controlled	water	
bath	 at	 80	 oC	 for	 4	 hrs.	 1.0	mL	 sample	 solutions	 were	 taken	
after	2	hrs	then	at	0.5	hr	intervals,	placed	into	25	mL	measuring	
flasks,	neutralized	with	1.0	mL	of	cold	0.2	M	hydrochloric	acid,	
then	 1	mL	 of	 2	M	 (NH4)2SO4	was	 added	 and	 the	 volume	was	
completed	with	BRP	pH	=	4.	The	solutions	[initial	concentration	
Co	=	200	μg/mL	were	measured	using	Sensor	1	by	immersing	it	
in	 conjunction	 with	 the	 single‐junction	 calomel	 reference	
electrode.	 The	 e.m.f	 values	 produced	 were	 recorded.	 The	
concentration	 of	 NFT	was	 calculated	 from	 the	 corresponding	
regression	 equation.	 The	 log	 %	 of	 remaining	 concentration	
against	time	was	plotted.	
	
2.3.10.2.	For	studying	the	effect	of	NaOH	concentration	on	
the	reaction	rate	
	
Into	 three	 50	 mL	 measuring	 flasks,	 0.25	 g	 of	 NFT	 was	
dissolved	in	0.20,	0.15	and	0.10	M	NaOH	and	completed	to	the	
mark	with	the	same	solvent.	These	solutions	were	transferred	
into	 other	 clean	 dry	 conical	 flasks,	 and	 then	 refluxed	 in	 a	
thermostatically	controlled	water	bath	at	80	oC	for	4	hrs.	1.0	mL	
sample	 solutions	 were	 taken	 after	 2	 hrs	 then	 at	 0.5	 hr	
intervalsand	 then	 complete	 as	 described	 under	 (For	 studying	
the	 kinetic	 order	 of	 the	 reaction).	 The	 log	 %	 of	 remaining	
concentration	 against	 time	 was	 constructed	 for	 different	
molarities	 of	 NaOH.	 The	 rates	 constant	 and	 there	
corresponding	half	lives	(t1/2)	were	calculated.	
	
2.3.10.3.	For	studying	the	effect	of	the	temperature	on	the	
reaction	rate	
	
Three	portions	each	of	0.25	g	of	NFT	were	dissolved	in	50	
mL	measuring	flasks	and	completed	to	volume	with	0.20,	0.15,	
and	 0.10	 M	 NaOH,	 respectively.	 These	 solutions	 were	
transferred	into	other	clean	dry	conical	flasks	and	then	refluxed	
in	a	thermostatically	controlled	water	bath	at	60,	70,	80	and	90	
oC	 for	20	min.	Sample	solutions	(1.0	mL)	were	taken	at	4	min	
intervals	and	 then	complete	as	described	under	 (For	studying	
the	kinetic	order	of	the	reaction).		
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Table	1.	Electrochemical	response	characteristics	of	the	two	investigated	electrodes.	
Parameter	 Sensor	1	 Sensor	2	
Slope	(mV/decade)a	 ‐56.9 ‐54.1
Intercept	(mV)	 255.8 ‐0.9
LOD	(mol/L)b	 1.1	x	10‐7 5.6	x	10‐6
Response	time	(seconds)	 7	 9
Working	pH	range	 2	‐	5 2	‐ 5
Concentration	range	(M)	 1	x	10‐6	‐ 1	x	10‐2 1	x	10‐5	‐ 1	x	10‐2	
Stability	(days)	 28	 14	
Average	recovery	(%)	±	S.D.a	 99.93±0.604	 99.97±0.890	
Correlation	coefficient	 0.9998 0.9993
a	Average	of	five	determinations.	
b	Limit	of	detection	(measured	by	the	interception	of	the	extrapolated	arms	of	Figure	3).	
	
	
The	 Log	 %	 of	 remaining	 concentration	 against	 time	 at	
different	temperatures	was	plotted.	Also	the	Arrhenius	plot	for	
the	 effect	 of	 temperature	 on	 the	 rate	 of	 hydrolysis	 was	
constructed.	
	
3.	Results	and	discussion	
	
The	molecular	recognition	and	 inclusion	complexation	are	
of	current	interest	in	host‐guest	and	supramolecular	chemistry	
and	 offer	 a	 promising	 approach	 to	 chemical	 sensing	 [49,50].	
The	 use	 of	 selective	 inclusion	 complexation	 with	 ion	
association	 complex	 and	 complementary	 ionic	 or	 hydrogen	
bonding	with	ionophores	are	two	main	strategies	for	preparing	
synthetic	 host	 molecules,	 which	 recognize	 the	 structure	 of	
guest	molecules	[51].	
A	microsized	graphite	and	platinum	wire	coated	with	 thin	
films	 of	 PVC‐TpClPB‐sulfocalix‐8‐arene	 were	 prepared	 and	
used	 as	 potentiometric	 sensors	 for	 NFT	 drug.	 Upon	 soaking	
these	 sensors	 in	 10‐2	 M	 drug	 solution,	 a	 homogenous	
electroactive	 polymer‐NFT	 site	 was	 formed,	 which	 induced	 a	
potentiometric	 response	 for	 the	 NFT	 cation	 through	 an	 ion‐
exchange	mechanism.	
	
3.1.	Performance	characteristics	of	NFT	sensors	
	
The	 sulphonated	 calyx‐8‐arene‐based	 showed	 the	 best	
Nernstian	 slope	 (56.4	 and	 54.1	 mV/decade)	 and	 selectivity	
coefficient	 values	 compared	 to	 reference	 [25]	 that	 used	 β‐
cyclodextrin	as	ionophore.	The	host‐guest	complex	is	stabilized	
via	 an	 electrostatic	 interaction	 between	 the	 cationic	 NFT	 and	
anionic	 sulphonated	 calyx‐8‐arene.	 Moreover,	 calyx‐8‐arene	
had	 a	 larger	 internal	 cavity	 size	 (9.5	 Å)	 [52]	 than	 2‐hydroxy	
propyl	cyclodextrin	(6	Å)	[53].	This	allows	the	drug	to	fit	well	in	
the	 calixarene	 cavity	 and	 strongly	 bond	 to	 the	 calixarene	
donation	 sites.	The	 results	 reveal	 that,	 as	 ionophore	provided	
high	 stability	 to	 the	 complexes	 formed	 with	 cationic	 drug	
present	 in	 solution;	 thus,	 the	 membrane	 selectivity	 and	
sensitivity	are	 substantially	enhanced.	Thus,	 in	 the	absence	of	
ionophores	 as	 in	 references	 [24,25],	 the	 lowest	 slope	 value	 is	
found	accompanied	by	the	highest	selectivity	coefficient	values.	
A	 higher	 selectivity	 coefficient	 value	 corresponds	 with	 more	
attack	by	 interfering	cations	on	the	electrode	membrane.	Also	
the	 incorporation	 of	 ion	 association	 complex	 (TpClPB)	 with	
ionophores	gives	better	selectivity	compared	to	reference	[25]	
which	used	ionophore	(β‐cyclodextrin)	only.	
The	 electrochemical	 performance	 characteristics	 of	 the	
proposed	 sensors	were	 systematically	 evaluated	 according	 to	
IUPAC	 standards	 [48].	 Table	 1	 showed	 the	 results	 obtained	
over	 a	 period	 of	 two	months	 for	 two	 different	 assemblies	 of	
each	sensor.	Typical	calibration	plots	were	shown	in	Figure	3.	
The	 slopes	 of	 the	 calibration	 plots	 were	 56.9	 and	 54.1	
mV/concentration	 decade	 for	 Sensors	 1	 and	 2,	 respectively.	
Deviation	 from	 the	 ideal	Nernstian	 slope	 (60	mV)	was	due	 to	
the	 electrodes	 responding	 to	 the	 activity	 of	 the	 drug	 cation	
rather	 than	 its	 concentration.	 The	 sensors	 displayed	 constant	
potential	 readings	 for	 day	 to	 day	 measurements,	 and	 the	
calibration	slopes	did	not	change	by	more	than	±2	mV/decade	
over	 a	 period	 of	 28	 and	 14	 days	 for	 Sensors	 1and	 2,	
respectively.	 The	 detection	 limits	 of	 the	 two	 sensors	 were	
estimated	 according	 to	 the	 IUPAC	 definition	 [48].	 Table	 1	
showed	 that	 Sensor	 2	 can	detect	NFT	 in	 very	dilute	 solutions	
down	to	1.1×10−7	mol/L.	This	agrees	with	the	idea	that	NFT	is	
typically	bonded	with	the	very	polar	sulphonic	acid	groups.	
	
Figure	3.	Profile	of	the	potential	in	mV	vs		Log	concentrations	of	NFT	in	
mol/L	obtained	with	Sensors	1	and	2.
	
3.2.	Dynamic	response	time	
	
Dynamic	response	time	is	an	important	factor	for	analytical	
applications	of	 ion‐selective	electrodes.	 In	 this	study,	practical	
response	 time	was	 recorded	 by	 increasing	NFT	 concentration	
by	 up	 to	 10‐fold.	 The	 required	 time	 for	 the	 sensors	 to	 reach	
values	within	 ±1	mV	 of	 the	 final	 equilibrium	 potential	 was	 7	
and	9	s	for	Sensors	1	and	2,	respectively.	
	
3.3.	Effect	of	pH	and	temperature	
	
For	 quantitative	 measurements	 with	 ion	 selective	
electrodes,	 studies	 were	 carried	 out	 to	 reach	 the	 optimum	
experimental	 conditions.	 The	 potential	 pH	 profile	 obtained	
indicated	 that	 the	 responses	 of	 the	 two	 sensors	 are	 fairly	
constant	 over	 the	 pH	 range	 2‐5	 (Figure	 4).	 Therefore,	 the	 pH	
range	from	2	to	5	was	assumed	to	be	the	working	pH	range	of	
the	 tow	 sensors.	 The	 results	 suggested	 that	 the	 electrodes	
exhibit	 a	 slight	 increase	 in	 their	 potential	 as	 the	 temperature	
rises	 in	 the	 range	 of	 20‐35	 oC.	 However,	 the	 calibration	 plots	
obtained	at	different	temperatures	were	parallel,	and	the	limit	
of	detection,	slope	and	response	time	do	not	significantly	vary	
with	 temperature	 indicating	 reasonable	 thermal	 stability	 of	
PVC	membranes	up	to	35	oC.	
	
3.4.	Sensors	selectivity	
	
Table	 2	 showed	 the	 potentiometric	 selectivity	 coefficients	
of	the	proposed	sensors	in	the	presence	of	its	degradate,	tablet	
excipients,	organic	and	inorganic	related	substance,	the	results	
revealed	 that	 the	proposed	membrane	sensors	displayed	high	
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selectivity,	 and	 that	 no	 significant	 interference	 was	 observed	
from	 interfering	 species.	 Also,	 they	 revealed	 that	 Sensor	 1	
displayed	 greater	 selectivity	 for	 ionic	 interfering	 species	 such	
as	NaCl,	KCl,	and	CaCl2	than	did	Sensor	2.	
	
Table	2.	Potentiometric	selectivity	coefficients	( pot
iK )	of	the	two	proposed	
sensors	using	the	separate	solutions	method	(SSM)	[48].	
Interferent	b	 Selectivity	coefficient	a	
Sensor	1 Sensor	2
Deg.product	c	 3.75	x	10‐2	 4.79	x	10‐2
2(Dimethyl	
amino)ethanol	
5.66	x	10‐2	 7.53	x	10‐2
KCl	 3.01	x	10‐3	 3.61	x	10‐2	
NaCl	 2.05	x	10‐3	 3.30	x	10‐2	
CaCl2	 2.67	x	10‐3	 3.36	x	10‐2
lactose	 3.51	x	10‐3	 3.52	x	10‐3	
Magnesium	stearate,	 3.14	x	10‐2	 3.05	x	10‐2
MgSO4	 3.15	x	10‐2	 3.18	x	10‐2
Urea	 2.92	x	10‐3	 2.67	x	10‐3
L‐phenyl	alanine	 2.92	x	10‐3	 3.18	x	10‐3
Starch	 3.88	x	10‐3	 3.56	x	10‐3
Talc	 4.09	x	10‐4	 4.21	x	10‐4
a	Each	value	is	the	average	of	three	determinations.	
b	All	interferents	are	in	the	form	of	1×10−3	mol/L	solution.	
c	Tetra‐hydro‐α‐(1‐naphthalenylmethyl)‐2‐furanpropanoic	acid.	
	
	
Sensor	1	
	
	
Sensor	1	
	
Figure	4.	Effect	of	pH	on	the	response	of	Sensor	1	and	2.	
	
3.5.	Potentiometric	determination	of	NFT	in	pharmaceutical	
formulations	
	
Table	3	showed	the	results	obtained	for	the	determination	
of	 NFT	 in	 pharmaceutical	 formulations	 (Praxilene®	 tablets),	
proving	the	applicability	of	the	method,	as	demonstrated	by	the	
accurate	and	precise	percentage	recovery;	the	results	obtained	
were	 also	 compared	 with	 those	 obtained	 by	 using	 official	
method	[3]	(Non‐aqueous	 titration	with	0.1	M	perchloric	acid,	
determining	 the	 end	 point	 potentiometrically).	 No	 significant	
difference	in	results	was	found.	Thus,	analysis	was	carried	out	
without	prior	treatment	or	extraction.	
	
3.6.	Potentiometric	determination	of	NFT	in	the	presence	of	
its	alkaline	degradate	
	
The	induced	alkaline	degradation	(Figure	5)	was	tested	by	
TLC	 and	 gas	 chromatography	 mass	 spectroscopic	 (GC/MS)	
methods.	 In	 TLC,	 the	 retardation	 factor	 (Rf)	 values	were	 0.79	
for	 NFT	 and	 0.71	 for	 degradate	 I.	 In	 GC‐MS,	 a	 parent	 peak	
appeared	at	m/z	=	284	 indicating	 the	molecular	weight	of	 the	
degradation	product	as	z	(The	charge)	is	one.		
Table	 4	 showed	 the	 results	 obtained	 upon	 analysis	 of	
synthetic	mixtures	containing	different	ratios	of	 intact	drug	to	
degraded	sample,	varying	from	10:1	to	1:5.	The	results	showed	
that	 Sensor	 1	 can	 be	 successfully	 used	 for	 selective	
determination	 of	 intact	 drug	 in	 the	 presence	 of	 >80%	 of	 the	
degradate.	 While	 Sensor	 2	 suffered	 from	 great	 interference	
when	 the	 degradate	 concentration	 is	 up	 to	 about	 50	%.	 Thus	
Sensor	 1	 was	 recommended	 for	 use	 in	 stability‐indicating	
methods.	
	
 
	
Figure	5.	Alkaline	degradation	of	naftidrofuryl	oxalate.
	
3.7.	Potentiometric	determination	of	NFT	in	plasma	and	CSF	
	
Tables	 5	 and	 6	 showed	 the	 results	 obtained	 for	 the	
determination	 of	 NFT	 in	 spiked	 human	 plasma	 and	
cerebrospinal	fluid	(CSF).		
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Table	3.	Determination	of	NFT	in	different	pharmaceutical	formulations	by	the	three	proposed	electrodes	and	the	official	method	[3].	
Praxilene®	tablets	claimed	to	contain	200	mg	 Recovery	(%)	±	S.D.	a	of	NFT	
Sensor	1 Sensor	2 Reported	method	b
Batch	numbercee	1446	 99.78±0.816	 99.23±0.937	 99.29±1.232	
t‐testc	 0.741(2.306)	 0.086(2.306)	 	
F	testc	 2.279(6.39) 1.728(6.39) 	
Batch	numbercce	0886	 99.09±0.804 99.11±0.975 99.51±1.225	
t‐testc	 0.640(2.306)	 0.571(2.306)	 	
F	testc	 2.321(6.39)	 1.578(6.39)	 	
a	Average	of	five	determinations.	
b	Non‐aqueous	titration	with	0.1	M	perchloric	acid,	determining	the	end	point	potentiometrically.	
c	The	values	in	parentheses	are	the	corresponding	theoretical	values	for	t	and	F	at	p	=	0.05	[57].	
	
Table	4.	Determination	of	NFT	in	laboratory	prepared	mixtures	containing	different	ratios	of	NFT	and	its	induced	alkaline	degradation	product	by	the	proposed	
sensors.	
Concentration	(M)	 Ratio	a Recovery	(%)	±	S.D.	b of	NFT
NFT	 Deg.	product	 Sensor	1 Sensor	2	
1	x	10‐3	 1	x	10‐4	 10:1	 99.17±0.831 100.54±0.990	
1	x	10‐3	 5	x	10‐4	 2:1	 99.36±0.825	 99.01±0.960	
1	x	10‐3	 1	x	10‐3	 1:1	 101.38±1.129	 110.96±1.137	
1	x	10‐3	 5	x	10‐3	 1:5	 102.14±1.007	 87.73±1.236	
a	Degradation	product:	Naftidofuryl	oxalate.	
b	Average	of	three	determinations.	
	
Table	5.	Determination	of	NFT	in	spiked	human	plasma	by	the	proposed	sensors.	
Added	(µg/mL)	 Recovery	(%)	±	S.D.	a	of	NFT
Sensor	1 Sensor	2
10‐4	(4.736)	 100.78±0.916 99.23±1.137
10‐6	(0.4736)	 102.09±1.306	 ‐	b	
a	Average	of	three	determinations.	
b	Out	of	range.	
	
Table	6.	Determination	of	NFT	in	spiked	cerebrospinal	fluid	by	the	proposed	sensors.	
Added	(µg/mL)	 Recovery	(%)	±	S.D.	a of	NFT
Sensor	1	 Sensor	2	
10‐5	(4.736)	 98.71±1.196 98.99±1.077
10‐6	(0.4736)	 98.90±1.242 ‐ b
a	Average	of	three	determinations.	
b	Out	of	range.	
	
	
It	 was	 clear	 from	 the	 results	 that	 a	 wide	 concentration	
range	 of	 the	 drug	 could	 be	 determined	 by	 the	 investigated	
sensors	as	 they	gave	stable	 results	 in	slopes	and	mV	readings	
revealed	 by	 the	 high	 precision	 and	 accuracy	 of	 the	 recovery	
results.	It	 is	also	clear	from	the	results	shown	that	Sensor	1	is	
more	 sensitive	 than	 Sensor	 2	 because	 wider	 concentration	
ranges	of	the	drug.	The	response	times	of	the	proposed	sensors	
are	instant	(within15	s),	so	the	sensors	are	rapidly	transferred	
back	 and	 forth	 between	 the	 biological	 samples	 and	 the	
deionised	bi‐distilled	water	between	measurements	to	protect	
the	 sensing	 component	 from	 adhering	 to	 the	 surface	 of	 some	
matrix	 components.	 It	 is	 concluded	 that	 the	proposed	sensors	
can	 be	 successfully	 applied	 to	 in	 vitro	 studies	 and	 for	 clinical	
use.	
	
3.8.	Kinetics	of	the	degradation	
	
The	 linear	 relationship	 (Figure	 6)	 between	 the	 Log	 %	 of	
remaining	 concentration	 against	 time	 indicated	 first‐order	
degradation.	 Since	 the	 hydrolysis	 was	 performed	 in	 a	 large	
excess	 of	 NaOH	 (0.2	 M),	 therefore	 it	 follows	 a	 pseudo‐first	
order	 reaction	 rate	 [54]	 which	 is	 the	 term	 used	 when	 two	
reactants	are	involved	in	the	reaction	but	one	of	them	is	in	such	
a	 large	 excess	 (NaOH)	 that	 any	 change	 in	 its	 concentration	 is	
negligible	 compared	 with	 the	 change	 in	 concentration	 of	 the	
other	reactant	(drug).	
Different	 parameters	 that	 affect	 the	 rate	 of	 the	 reaction	
were	studied.	The	temperature	dependence	of	NFT	degradation	
was	 studied	 by	 conducting	 the	 reaction	 at	 different	
temperatures	 using	 different	 concentrations	 of	 the	 alkaline	
solution	(Figure	7).	At	each	temperature	the	rate	constant	and	
t1/2	 were	 calculated	 then	 the	 log	 of	 the	 rate	 constant	 was	
plotted	against	the	reciprocal	of	the	temperature	in	Kelvin	units	
(Arrhenius	 plot,	 Figure	 8)	 to	 demonstrate	 the	 effect	 of	
temperature	on	the	rate	constant.	It	was	concluded	that	as	the	
temperature	 increased	 the	rate	of	hydrolysis	 increased	with	a	
decrease	in	the	t1/2	(Table	7).	Also,	the	energy	of	activation	was	
determined	by	calculating	the	rate	constant	from	the	equation	
(2)	[55].	
	
	
	
Figure	6.	First	order	plot	of	the	hydrolysis	of	NFT	(1000	mg	%)	with	0.2	M	
NaOH	at	80	oC	(Co	=	Initial	concentration,	CT	=	Concentration	at	time	(T)).	
	
2 2 1
1 1 2
log ( )
2.303 .
aEk T T
k R T T


	 	 	 (2)
	
	
where	 Ea	 is	 the	 activation	 energy,	 T1	 and	 T2	 are	 the	 two	
temperatures	 degrees	 in	 Kelvin,	 R	 is	 the	 gas	 constant,	 and	 k1	
and	k2	are	the	rate	constants	at	the	two	temperatures	used.		
The	calculated	Ea	was	 found	 to	be	12.572	Kcal/mol	which	
was	 a	moderate	 value	 for	 esters,	 suggesting	 the	 instability	 in	
alkaline	medium	[56].	
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Table	7.	Kinetic	data	of	naftidrofuryl	alkaline	degradation.	
Concentration	of	NaOH,	(M)	 Temperature	(oC) k	(h‐1) t1/2	(h)	
0.20		 90	 0.758 0.91	
80	 0.446	 1.48	
70	 0.295	 2.34	
60	 0.162	 4.27	
0.15	 90	 0.602 1.15	
80	 0.346 2.00	
70	 0.220 3.15	
60	 0.117	 5.92	
0.10	 90	 0.398 1.74	
80	 0.223 3.10	
70	 0.128 5.41	
60	 0.079 8.77	
	
	
	
	
	
	
	
	
Figure	7.	First	order	plot	of	 the	hydrolysis	of	NFT	(1000	mg	%)	with	0.20,	
0.15	 and	0.10	M	NaOH	 at	 different	 temperatures	 (Co=initial	 concentration,	
CT=	concentration	at	time	(T)).	
	
Another	 factor	 that	 affects	 the	 rate	 of	 the	 reaction	 is	 the	
concentration	of	NaOH,	 thus	different	molarities	were	used	 to	
study	the	hydrolysis	reaction.	The	rate	of	hydrolysis	increased	
with	 increasing	 NaOH	 concentration,	 although	 the	 effect	 was	
minor	 compared	 to	 the	 effect	of	 temperature	 (Figure	7,	Table	
7).	
In	conclusion,	 the	alkaline	hydrolysis	of	NFT	was	 found	to	
follow	 a	 pseudo	 first	 order	 reaction.	 Also	 the	 reaction	 rate	
increases	with	increase	in	the	temperature	and	the	strength	of	
the	alkaline	solution.	
		
	
	
Figure	8.	Arrhenius	plot	for	the	hydrolysis	of	NFT	(1000	mg	%)	with	0.20,	
0.15	and	0.10	M	NaOH.
	
4.	Conclusion	
	
The	described	sensors	are	sufficiently	simple	and	selective	
for	 the	 quantitative	 determination	 of	 NFT	 in	 pure	 form,	
pharmaceutical	formulations,	in	the	presence	of	its	degradation	
products,	 in	 plasma	 and	 CSF.	 The	 use	 of	 sulphonated	 calix‐8‐
arene	 as	 ionophores	 increased	 the	membrane	 sensitivity.	 The	
proposed	 sensors	 offer	 advantages	 of	 fast	 response	 and	
elimination	of	drug	pre‐treatment	or	separation	steps.	They	can	
therefore	be	used	for	routine	analysis	of	NFT	in	quality‐control	
laboratories.	
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